Following the launch of two new cancer tests—plus a third planned for before the end of 2025—Exact Sciences is nudging up its ...

By analysing DNA from blood samples, Tvaster Genkalp is working to make cancer diagnostics more accessible, accurate, and ...

Twist Bioscience Corporation’s TWST share price has dipped by 8.55%, which has investors questioning if this is right time to buy.

An emerging oncology tool known as broad genomic profiling or BGP is increasingly being used to help identify targeted ...

A panelist discusses how education and cost are key challenges in ensuring comprehensive molecular testing is performed in a ...

A study of human tumor cells implanted in mice from the MacPherson Lab at Fred Hutch describes a new way to screen for the ...

The Bell County Sheriff’s Office will be getting a new tool to collect DNA evidence to help with both cold cases and new ones ...

National Jewish Health researchers with the Advanced Diagnostic Laboratories have developed a molecular diagnostic test ...

Another woman spoke about how biomarker testing allowed her oncologists to provide a detailed plan of attack against her breast cancer. Some private insurance already covers the procedure.